Researchers in China built a multimodal AI framework combining clinical data, CT enterography radiomics and deep learning on double-balloon enteroscopy images that outperformed single-modality models in...
Obesity-focused Zealand Pharma is buying into Generate:Biomedicines’s generative AI platform to create new multispecific drug candidates.
Zealand has added another strand to its programme of weight-loss drug development, linking with AI player Generate on multispecific protein therapies.
A Transformer deep learning model predicts cancer cell fates directly from live-cell videos with high accuracy up to eight hours before the outcome occurs.
BIOCENTURY | GUEST COMMENTARYWHAT BIOTECHNOLOGY CAN TEACH POLICYMAKERS ABOUT HOW TO REGULATE AIDrawing on biotech’s history to propose enforceable safeguards for AI research that evolve as...
Next-gen sequencing is leveraging AI, multiomics assays, streamlined workflows and other approaches to deliver richer content at ever-lower overall costs. The post Trends in NGS appeared...
An academic laboratory is developing a hybrid digital twin that integrates a mechanistic model with artificial intelligence, with the long-term goal of driving the future of...
Low-fidelity trend information should be incorporated into the data sets used to train machine learning-based biopharmaceutical process models, according to new analysis, which suggests the approach...
The renewed arrangement will see Cognizant combine its life sciences sector knowledge with technical services to aid Gilead’s ongoing development and operational processes. The joint work...
Across 14 genetic perturbation datasets and 18 evaluation metrics, commonly used measures such as mean squared error and control-referenced Pearson correlation were often poorly calibrated, particularly...
Scan to Read